We are looking very much forward to next week’s EMIM 2019 in the Clyde metropolis. Proud to say we have got three oral presentations accepted!
Listen to Candice and Yasmin reporting on rendering iPSC-derived hepatocytes and therapeutic Tregs in vivo traceable, and find out what Alessia observed tracking anti-ErbB CAR-T retention in triple negative breast cancer models.
The Fruhwirth Lab 